Insider trades

Philippe Menu, Chief Officer of SOPHiA Genetics SOPH, has filed 0 purchases and 16 sales on the open market. Over the past 12 months that comes to a net sale of $227.1K. The latest trade was on 06/25.

Philippe Menu

Chief Medical Officer
First filing
25/01/27
Trades
20 trades
Buys / sales
0 / 16
12-month net buying
−$227.1K
Last trade
06/25

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan06/2506/265,000 sh$5.50$27,500−2.0%
Open-market sale10b5-1 plan06/1206/155,000 sh$4.95$24,750−2.0%
Open-market sale10b5-1 plan05/2606/015,000 sh$4.95$24,750−2.0%
Open-market sale10b5-1 plan05/1905/20608 sh$4.61$2,802.88−0.2%
Open-market sale10b5-1 plan05/1205/135,000 sh$4.67$23,350−1.9%
Open-market sale10b5-1 plan04/2704/285,000 sh$4.82$24,100−1.9%
Open-market sale10b5-1 plan04/2004/21608 sh$5.20$3,161.6−0.2%
Open-market sale10b5-1 plan04/1404/161,600 sh$4.96$7,936−0.6%
SOPH
Open-market sale10b5-1 plan04/10–04/1304/148,125 sh3 trades$4.72avg.$38,377−2.9%
SOPH
Open-market sale10b5-1 plan04/08–04/0904/104,731 sh2 trades$4.80avg.$22,704.94−1.7%
SOPH
Open-market sale10b5-1 plan04/06–04/0704/085,100 sh2 trades$4.86avg.$24,783−1.8%
Open-market sale10b5-1 plan03/1903/20608 sh$4.79$2,912.32−0.3%